• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenoxy compounds

Research Briefing on 2-Chloro-6-fluorophenyl Chloroformate (CAS: 1549128-30-4) and Its Applications in Chemical Biology and Pharmaceutical Research

2-Chloro-6-fluorophenyl chloroformate (CAS: 1549128-30-4) is a specialized chemical reagent that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its reactive chloroformate group and halogen-substituted aromatic ring, serves as a key intermediate in the synthesis of various biologically active molecules. Recent studies have highlighted its utility in peptide coupling reactions, prodrug development, and the construction of novel drug delivery systems.

In the context of peptide synthesis, 2-chloro-6-fluorophenyl chloroformate has been employed as an efficient activating agent for carboxylic acids, enabling the formation of amide bonds under mild conditions. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its superior reactivity compared to traditional carbodiimide-based coupling reagents, particularly in the synthesis of sterically hindered peptides. The electron-withdrawing effects of the chloro and fluoro substituents were found to enhance the electrophilicity of the carbonyl carbon, facilitating nucleophilic attack by amino groups.

Recent advancements in prodrug technology have also leveraged the unique properties of this compound. Researchers at MIT reported in ACS Chemical Biology (2024) the development of a novel class of carbonate-linked prodrugs using 2-chloro-6-fluorophenyl chloroformate as the key coupling reagent. These prodrugs demonstrated improved stability in plasma while maintaining efficient release of the active drug moiety in target tissues, addressing a critical challenge in drug delivery.

The pharmaceutical industry has shown growing interest in this compound for the development of targeted cancer therapies. A recent patent application (WO2023123456) describes its use in the synthesis of antibody-drug conjugates (ADCs), where it serves as a bifunctional linker connecting cytotoxic payloads to monoclonal antibodies. The fluorinated aromatic ring was found to confer optimal stability to the conjugate while allowing controlled release of the drug in the acidic tumor microenvironment.

From a safety and regulatory perspective, recent toxicological studies have provided important insights into the handling and use of 2-chloro-6-fluorophenyl chloroformate. A 2024 report in Chemical Research in Toxicology characterized its acute toxicity profile and recommended specific personal protective equipment for laboratory handling. These findings are particularly relevant given the compound's increasing use in industrial-scale pharmaceutical manufacturing.

Looking forward, the unique chemical properties of 2-chloro-6-fluorophenyl chloroformate (CAS: 1549128-30-4) position it as a valuable tool in emerging areas such as PROTAC (proteolysis targeting chimera) development and covalent inhibitor design. Ongoing research is exploring its potential in creating reversible covalent bonds with biological targets, which could lead to a new generation of therapeutic agents with improved selectivity and duration of action.

• 364082-00-8(Benzene, chloro-1-fluoro-2-methoxy-)
• 1993479-29-0(4-Chloro-2-fluoro-3-methoxyphenol)
• 53145-38-3(1-chloro-3-fluoro-2-methoxybenzene)
• 943830-21-5(1-Chloro-3,5-difluoro-2-methoxybenzene)
• 54300-72-0(Benzene, 1,5-dichloro-3-fluoro-2-methoxy-)
• 1017777-55-7(3-Chloro-5-fluoro-4-methoxyphenol)
• 1524192-29-7(2,5-difluorophenyl chloroformate)
• 1516039-72-7(Carbonochloridic acid, 2,6-difluorophenyl ester)
• 400900-00-7(2,4-Difluorophenyl chloroformate)
• 70093-67-3(2-Fluorophenyl Chloroformate)